Literature DB >> 6413695

Involvement of dorsal root ganglia in Fabry's disease.

N Gadoth, U Sandbank.   

Abstract

Bouts of shooting pain along the extremities are common in the early stages of Fabry's disease. No pathological explanation has been advanced to clarify the mechanism of such pain. In the present case neuronal storage of glycolipid was confined to dorsal root ganglia neurones only. It is suggested that this may explain the shooting pain in Fabry's disease. In hereditary sensory radicular neuropathy, familial dysautonomia, and tabes dorsalis, changes in dorsal root ganglia cells cause similar clinical signs and thus it may be concluded that shooting pains in Fabry's disease may be caused by damage to dorsal root ganglia neurones.

Entities:  

Mesh：

Year:  1983        PMID： 6413695      PMCID： PMC1049127          DOI： 10.1136/jmg.20.4.309

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


  10 in total

1.  THE NEUROPATHOLOGY OF HEREDITARY DYSTOPIC LIPIDOSIS.

Authors:  A N RAHMAN; R LINDENBERG
Journal:  Arch Neurol       Date:  1963-10

2.  Hereditary sensory radicular neuropathy.

Authors:  D DENNY-BROWN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1951-11       Impact factor: 10.154

3.  Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns.

Authors:  A Onishi; P J Dyck
Journal:  Arch Neurol       Date:  1974-08

4.  the central nervous system in Fabry's disease. A clinical, pathological, and biochemical investigation.

Authors:  H O Lou; E Reske-Nielsen
Journal:  Arch Neurol       Date:  1971-10

5.  Neuropathological and biochemical studies in Fabry's disease.

Authors:  T Tabira; I Goto; Y Kuroiwa; M Kikuchi
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

6.  On the pathology of angiokeratoma corporis diffusum (Fabry).

Authors:  E Jensen
Journal:  Acta Pathol Microbiol Scand       Date:  1966

7.  Autonomic neurons affected by lipid storage in the spinal cord in Fabry's disease: distribution of autonomic neurons in the sacral cord.

Authors:  J H Sung
Journal:  J Neuropathol Exp Neurol       Date:  1979-03       Impact factor: 3.685

8.  Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia.

Authors:  J Pearson; B A Pytel; N Grover-Johnson; F Axelrod; J Dancis
Journal:  J Neurol Sci       Date:  1978-01       Impact factor: 3.181

9.  Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain.

Authors:  P Kahn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154

10.  Fabry's disease (angiokeratoma corporis diffusum). A report of 5 cases with pain in the extremities as the chief symptom.

Authors:  V W Steward; C Hitchcock
Journal:  Pathol Eur       Date:  1968
  10 in total
  20 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease.

Authors:  Tim Godel; Anja Köhn; Nicole Muschol; Moritz Kronlage; Daniel Schwarz; Jennifer Kollmer; Sabine Heiland; Martin Bendszus; Victor-Felix Mautner; Philipp Bäumer
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

3.  Development of a model system for neuronal dysfunction in Fabry disease.

Authors:  Christine R Kaneski; Roscoe O Brady; John A Hanover; Ulrike H Schueler
Journal:  Mol Genet Metab       Date:  2016-07-22       Impact factor: 4.797

4.  Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.

Authors:  M Ries; H J Kim; C K Zalewski; M A Mastroianni; D F Moore; R O Brady; J M Dambrosia; R Schiffmann; C C Brewer
Journal:  Brain       Date:  2006-11-14       Impact factor: 13.501

5.  Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement.

Authors:  Raphael Schiffmann; Amy Rapkiewicz; Mones Abu-Asab; Markus Ries; Hasan Askari; Maria Tsokos; Martha Quezado
Journal:  Virchows Arch       Date:  2005-11-29       Impact factor: 4.064

6.  Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease.

Authors:  John Marshall; Karen M Ashe; Dinesh Bangari; KerryAnne McEachern; Wei-Lien Chuang; Joshua Pacheco; Diane P Copeland; Robert J Desnick; James A Shayman; Ronald K Scheule; Seng H Cheng
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

7.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183

8.  Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y.

Authors:  Tim Godel; Philipp Bäumer; Katharina Stumpfe; Nicole Muschol; Moritz Kronlage; Merle Brunnée; Jennifer Kollmer; Sabine Heiland; Martin Bendszus; Victor-Felix Mautner
Journal:  J Neurol       Date:  2019-03-04       Impact factor: 4.849

9.  Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical study.

Authors:  Surya N Gupta; Markus Ries; Gary J Murray; Jane M Quirk; Roscoe O Brady; Jeffrey R Lidicker; Raphael Schiffmann; David F Moore
Journal:  BMC Neurol       Date:  2008-11-06       Impact factor: 2.474

10.  Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment.

Authors:  Juan M Politei; Didier Bouhassira; Dominique P Germain; Cyril Goizet; Antonio Guerrero-Sola; Max J Hilz; Elspeth J Hutton; Amel Karaa; Rocco Liguori; Nurcan Üçeyler; Lonnie K Zeltzer; Alessandro Burlina
Journal:  CNS Neurosci Ther       Date:  2016-03-28       Impact factor: 5.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.